# Forensic Dossier: Study Forensics: Gene therapy elevating Klotho protein extends lifespan in mice

**Run ID:** `full27_study-forensics-024_Claude_Opus_4531e4`  
**Task:** study-forensics-024 | study_forensics | hard | study_forensics  
**Timestamp:** 2026-04-08T17:58:20.546682+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** animal_to_human_overreach  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Opus
**Winner:** Claude Opus — **71.7/100** (margin: 0.0)
**Failure modes:** decorative_uncertainty, missed_key_insight
**Forensic flags:** 1
**Consistency findings:** 7
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Opus | 30.0/30 | 2.4/8 | 5.3/8 | 3.9/6 | 3.3/6 | 5.2/6 | 3.6/8 | 8.0/8 | 0.0/10 | 10.0/10 | **71.7/100** |

## Study Forensics Audit

### Claude Opus

**Classification:** `mechanism_vs_evidence` [+] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 67%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Missed Findings:** unsupported_generalization
**Extra Findings:** cautious_scope_control

## Reasoning Integrity Audit

### Claude Opus
**Classification:** Correct and well-supported
**Load-bearing steps:** 1 / 6

## Mechanism Analysis

### Claude Opus
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Opus
Conclusion claims: 1
- Direct support: 0
- Indirect support: 1
- Unsupported: 0
- Contradicted: 0


## Forensic Flags

### Claude Opus

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "mechanism_vs_evidence"


## Evidence Map

### Claude Opus

**Correctness:** 30.0/30
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 2.4/8
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Conclusion grounded by reasoning chain_
  - Note: Support classification: 0 load-bearing, 1 supporting, 0 mentioned / 6
  - Note: Reasoning graph confirms conclusion grounding

**Structural Reasoning:** 5.3/8
  - (+) `steps[1]`: "Identified conclusion tier: human therapeutic implied by 'healthier society' and patent filing for treating human defici"
    _Most informative reasoning step_
  - Note: 6 reasoning steps
  - Note: Low step utility: 1/6 steps contribute

**Assumption Discipline:** 3.9/6
  - (+) `assumptions[2]`: "The patent filing and 'healthier society' language implies intended human therapeutic use"
    _Most substantive assumption_
  - Note: 3/3 substantive assumptions

**Uncertainty Handling:** 3.3/6
  - (+) `uncertainties[0]`: "Whether any human safety or preliminary data exists but wasn't mentioned"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.9"
    _Stated confidence level_
  - (-) `uncertainties[1]`: "The exact scope of the patents filed"
    _Listed but never addressed in reasoning_
  - (-) `uncertainties[2]`: "Whether 'international team' implies multiple institutions or countries"
    _Listed but never addressed in reasoning_
  - Note: 3 uncertainties (3 substantive)
  - Note: 2 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 5.2/6
  - (+) `alternative_hypotheses[1]`: "solid - if interpreted as purely reporting mouse findings, but the human therapeutic implications are clear"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 1/2 include rejection reasoning

**Self Monitoring Quality:** 3.6/8
  - (+) `self_check[0]`: "Confirmed the text does imply human benefit through patent filing and 'healthier society' language"
    _Most substantive self-verification step_
  - (-) `self_check[1]`: "Verified no human data is mentioned"
    _Fluff self-check_
  - Note: 4 self-check items
  - Note: Self-check quality: 0 deep, 3 arithmetic, 1 fluff

**Mechanism Quality:** 0.0/10
  - Note: Neither names concept nor explains mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.81, 236 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Opus

**MODERATE:**
- **Missed Key Insight** `[MEDIUM CONFIDENCE]`: Missed expected finding: unsupported_generalization
  - `(task expectation)`: "Expected: unsupported_generalization"
  - _Impacts: insight_depth_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'The exact scope of the patents filed...' is listed but not addressed
  - `uncertainties[1]`: "The exact scope of the patents filed"
  - _Impacts: uncertainty_handling_
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Whether 'international team' implies multiple institutions o...' is listed but not addressed
  - `uncertainties[2]`: "Whether 'international team' implies multiple institutions or countries"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Opus

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/8 content words)
  - `key_claims[0]`: "Mouse longevity increased 15-20% with Klotho gene therapy"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/6 content words)
  - `key_claims[1]`: "Improvements seen in multiple aging markers in mice"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/5 content words)
  - `key_claims[2]`: "Patents filed for human therapeutic applications"
- **[WARN]** `[HEURISTIC]` `claim_step_alignment`: Key claim 2 not well supported in reasoning steps (0/6 content words found)
  - `key_claims[1]`: "Improvements seen in multiple aging markers in mice"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 2 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[1]`: "The exact scope of the patents filed"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 3 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[2]`: "Whether 'international team' implies multiple institutions or countries"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "overclaim - could argue the 'healthier society' claim exceeds evidence"


## Agent Profiles

### Claude Opus (claude-opus-4-20250514)
**Parse OK:** True | **Latency:** 17675ms

**Final Answer:** mechanism_vs_evidence

**Confidence:** 0.9

**Assumptions:**
- The study was conducted only on mice based on 'middle-aged mice' reference
- The 'suitable delivery method' comment refers to future human application
- The patent filing and 'healthier society' language implies intended human therapeutic use

**Reasoning Steps:**
1. Identified evidence tier: mouse study with lifespan, muscle, bone, and cognitive outcomes
2. Identified conclusion tier: human therapeutic implied by 'healthier society' and patent filing for treating human deficits
3. Detected bridge step: from mouse longevity/health data to human therapeutic application
4. Evaluated bridge support: no human data mentioned, only future-oriented language about delivery methods
5. Checked for rhetorical inflation: language is relatively measured, not hyperbolic
6. Applied priority rule: since text is analytical rather than promotional, mechanism_vs_evidence takes precedence

**Key Claims:**
- Mouse longevity increased 15-20% with Klotho gene therapy
- Improvements seen in multiple aging markers in mice
- Patents filed for human therapeutic applications
- Human benefit implied despite only animal evidence

**Alternative Hypotheses:**
- overclaim - could argue the 'healthier society' claim exceeds evidence
- solid - if interpreted as purely reporting mouse findings, but the human therapeutic implications are clear

**Uncertainties:**
- Whether any human safety or preliminary data exists but wasn't mentioned
- The exact scope of the patents filed
- Whether 'international team' implies multiple institutions or countries

**Self-Verification:**
- Confirmed the text does imply human benefit through patent filing and 'healthier society' language
- Verified no human data is mentioned
- Checked that hedging ('suitable delivery method') acknowledges but doesn't resolve the tier gap
- Ensured not overflagging - the human implications are explicitly stated, not inferred

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 2.4/8 `###.......`
- Structural Reasoning: 5.3/8 `######....`
- Assumption Discipline: 3.9/6 `######....`
- Uncertainty Handling: 3.3/6 `#####.....`
- Alternative Hypothesis Quality: 5.2/6 `########..`
- Self Monitoring Quality: 3.6/8 `####......`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 0.0/10 `..........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Opus** scored **71.7/100**.

**Best per dimension:**
- Correctness: Claude Opus (30.0/30)
- Support Strength: Claude Opus (2.4/8)
- Structural Reasoning: Claude Opus (5.3/8)
- Assumption Discipline: Claude Opus (3.9/6)
- Uncertainty Handling: Claude Opus (3.3/6)
- Alternative Hypothesis Quality: Claude Opus (5.2/6)
- Self Monitoring Quality: Claude Opus (3.6/8)
- Insight Depth: Claude Opus (8.0/8)
- Mechanism Quality: Claude Opus (0.0/10)
- Communication Efficiency: Claude Opus (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Opus | 17.7s | 71.7/100 | 4.1 |

Failure modes observed: decorative_uncertainty, missed_key_insight.
